<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:hpo ids='HP_0000528'>Anophthalmia</z:hpo> and <z:hpo ids='HP_0000568'>microphthalmia</z:hpo> are etiologically and clinically <z:hpo ids='HP_0001425'>heterogeneous</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Lenz <z:hpo ids='HP_0000568'>microphthalmia</z:hpo> is a syndromic form that is typically inherited in an <z:hpo ids='HP_0001417'>X-linked</z:hpo> pattern, though the causative gene mutation is unknown </plain></SENT>
<SENT sid="2" pm="."><plain><z:e sem="disease" ids="C0265246,C1531578" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Townes-Brocks syndrome</z:e> manifests thumb anomalies, <z:mp ids='MP_0003130'>imperforate anus</z:mp>, and <z:hpo ids='HP_0000598'>ear anomalies</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>We present a 13-year-old boy with a syndromic <z:hpo ids='HP_0000568'>microphthalmia</z:hpo> phenotype and a clinical diagnosis of Lenz <z:hpo ids='HP_0000568'>microphthalmia</z:hpo> syndrome </plain></SENT>
<SENT sid="4" pm="."><plain>CASE PRESENTATION: The patient was subjected to clinical and molecular evaluation, including array CGH analysis </plain></SENT>
<SENT sid="5" pm="."><plain>The clinical features included left clinical <z:hpo ids='HP_0000528'>anophthalmia</z:hpo>, right <z:hpo ids='HP_0000568'>microphthalmia</z:hpo>, <z:hpo ids='HP_0001545'>anteriorly placed anus</z:hpo> with <z:mpath ids='MPATH_70'>fistula</z:mpath>, <z:hpo ids='HP_0000041'>chordee</z:hpo>, <z:hpo ids='HP_0001629'>ventriculoseptal defect</z:hpo>, <z:hpo ids='HP_0001643'>patent ductus arteriosus</z:hpo>, <z:hpo ids='HP_0000358'>posteriorly rotated ears</z:hpo>, <z:mp ids='MP_0004144'>hypotonia</z:mp>, <z:hpo ids='HP_0001510'>growth retardation</z:hpo> with <z:hpo ids='HP_0002750'>delayed bone age</z:hpo>, and <z:hpo ids='HP_0001249'>mental retardation</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>The patient was found to have an approximately 5.6 Mb deletion of 16q11.2q12.1 by microarray based-comparative genomic hybridization, which includes the SALL1 gene, which causes <z:e sem="disease" ids="C0265246,C1531578" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Townes-Brocks syndrome</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: Deletions of 16q11.2q12.2 have been reported in several individuals, although those prior reports did not note <z:hpo ids='HP_0000568'>microphthalmia</z:hpo> or <z:hpo ids='HP_0000528'>anophthalmia</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>This region includes SALL1, which causes <z:e sem="disease" ids="C0265246,C1531578" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Townes-Brocks syndrome</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>In retrospect, this child has a number of features that can be explained by the SALL1 deletion, although it is not clear if the <z:hpo ids='HP_0000568'>microphthalmia</z:hpo> is a rare feature of <z:e sem="disease" ids="C0265246,C1531578" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Townes-Brocks syndrome</z:e> or caused by other mechanisms </plain></SENT>
<SENT sid="10" pm="."><plain>These data suggest that rare copy number changes may be a cause of syndromic <z:hpo ids='HP_0000568'>microphthalmia</z:hpo> allowing a personalized genomic medicine approach to the care of patients with these aberrations </plain></SENT>
</text></document>